12:00 AM
 | 
Feb 16, 2015
 |  BC Week In Review  |  Company News  |  Deals

CytoSorbents, Aferetica deal

CytoSorbents granted Aferetica exclusive, Italian distribution rights to CytoSorb cytokine reduction therapy for critical care applications. The extracorporeal cytokine...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >